今开:3.38 | 昨收:3.37 |
最高:3.43 | 最低:3.3 |
涨停价:0.0 | 跌停价:0.0 |
总市值:4.99578618E8 |
观自在的悉达多04-15 14:17
利好$Adaptive(ADPT)$ ,这是全球做血液肿瘤MRD的领先公司,不同于实体瘤MRD,血液肿瘤在算法上要更加复杂一点,尤其是免疫重排类的检测,也比实体瘤走的更快。查看全文
Adaptive(ADPT)04-06 04:35
$Adaptive(ADPT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-042291 Act: 34 Size: 198 KB 网页链接查看全文
Adaptive(ADPT)04-10 05:35
$Adaptive(ADPT)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001193125-24-090983 Act: 34 Size: 181 KB 网页链接查看全文
Adaptive(ADPT)05-08 04:25
$Adaptive(ADPT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-054513 Act: 34 Size: 683 KB 网页链接查看全文
观自在的悉达多05-08 23:02
$Adaptive(ADPT)$ 血液肿瘤检测的小众公司,细分领域top1。2024年第一季度的收入为4190万美元。MRD业务贡献了78%的收入,与2023年第一季度相比增长了52%。其MRD已被美国食品药品监督管理局的肿瘤药物咨询委员会(ODAC)一致投票赞成使用MRD作为主要终点,以支持加速批准多发性骨髓瘤患者的新疗法。...查看全文
Adaptive(ADPT)05-29 04:35
$Adaptive(ADPT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001319244-24-000044 Act: 34 Size: 95 KB 网页链接查看全文
Adaptive(ADPT)04-27 04:35
$Adaptive(ADPT)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-118185 Act: 34 Size: 422 KB 网页链接查看全文
Adaptive(ADPT)06-12 04:25
$Adaptive(ADPT)$ 8-K Current report, items 5.07 and 8.01 Accession Number: 0000950170-24-071913 Act: 34 Size: 177 KB 网页链接查看全文
Adaptive(ADPT)05-08 04:35
$Adaptive(ADPT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-054604 Act: 34 Size: 8 MB 网页链接查看全文
Adaptive(ADPT)05-18 06:45
$Adaptive(ADPT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-010709 Size: 4 KB 网页链接查看全文
金刚小黄人2014-06-24 11:29
本周19家公司IPO 对新股感兴趣的欢迎来探讨 群组"美股新股和FDA讨论",欢迎点此申请加入: 网页链接 (请看好美股群!纯看不沟通禁入!)$迅雷(XNET)$ $阿戴普科技(ADPT)$ $GoPro(GPRO)$ $东北石油(NEP)$ $SNDX(SNDX)$ $美国医疗服务(AMPH)$查看全文
智通财经APP获悉,高盛分析师Salveen Richter将Adaptive Biotechnologies(ADPT.US)的评级从“买入”下调至“持有”,将目标价从74美元下调至63美元,理由是罗氏(Roche)旗下基因泰克(Genentech)公司打算暂停与Adaptive合作开发的基于T细... 网页链接
$Adaptive(ADPT)$ 8-K Current report, items 5.07 and 8.01 Accession Number: 0000950170-24-071913 Act: 34 Size: 177 KB 网页链接
$Adaptive(ADPT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001319244-24-000044 Act: 34 Size: 95 KB 网页链接
$Adaptive(ADPT)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-146738 Act: 34 Size: 15 KB 网页链接
$Adaptive(ADPT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-010709 Size: 4 KB 网页链接
$Adaptive(ADPT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-054604 Act: 34 Size: 8 MB 网页链接
$Adaptive(ADPT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-054513 Act: 34 Size: 683 KB 网页链接
$Adaptive(ADPT)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-118202 Act: 34 Size: 1 MB 网页链接
$Adaptive(ADPT)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-118168 Act: 34 Size: 2 MB 网页链接
$Adaptive(ADPT)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-118185 Act: 34 Size: 422 KB 网页链接
$Adaptive(ADPT)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001193125-24-090983 Act: 34 Size: 181 KB 网页链接